Baixe o app para aproveitar ainda mais
Prévia do material em texto
Controle Microbiano II Antibioticos Antibioticos – definicoes precisos • Os produtos microbianas mais importantes • Definição microbiologico: Substancia química produzido por m/o que inibe crescimento ou mata outros m/os • Definicao mais amplo (farmacia): Qualquer substancia quimica de qualquer tipo de celula (ate planta) que inibe ou mata celulas de outros organismos • No definicao microbiologico - Metabolitos secundários produzidos por fungos filamentosos e bactérias Antibioticos Semisinteticos - moleculas produzidas por microbios que sao modificados via quimica organica para aumentar atividade antimicrobiana ou modificar suficientemente para gerar novo patente ! Caracteristicas de Antibioticos Efeitos - cida (mata) ou estatica (inhibitoria) effect Espectro de acao – gama de mos afetados por certo antibiotico Largo espectro – mata gama grande de bacterias Gram-positivos e Gram-negativos Estreito espectro – efetivo contra Gram-positivos OU Gram-negativos Espectro limitado – efetivo contra um organismo so Espectros diversos Caracteristicas ideias de antibiotico clinicamente util: -Largo espectro -nao toxico no hospedeiro, sem efeitos colaterias -nao alergenico no hospedeiro -nao elimina microbiota normal no hospedeiro -alcance regiao do hospedeiro onde infeccao ocorre (ex - nao inativado pelo suco gastrico ou proteinas do sangue) -barato e facil de producao -Quimicamente estavel (longo prazo de validade) -Desenvolvimento de resistencia microbiana raro Some clinically important antibiotics Antibiotic Producer organism Activity Site or mode of action Penicillin Penicillium chrysogenum Gram-positive bacteria Wall synthesis Cephalosporin Cephalosporium acremonium Broad spectrum Wall synthesis Griseofulvin Penicillium griseofulvum Dermatophytic fungi Microtubules Bacitracin Bacillus subtilis Gram-positive bacteria Wall synthesis Polymyxin B Bacillus polymyxa Gram-negative bacteria Cell membrane Microrganismos, alvo, e modo de acao Polymyxin B Bacillus polymyxa Gram-negative bacteria Cell membrane Amphotericin B Streptomyces nodosus Fungi Cell membrane Erythromycin Streptomyces erythreus Gram-positive bacteria Protein synthesis Neomycin Streptomyces fradiae Broad spectrum Protein synthesis Streptomycin Streptomyces griseus Gram-negative bacteria Protein synthesis Tetracycline Streptomyces rimosus Broad spectrum Protein synthesis Vancomycin Streptomyces orientalis Gram-positive bacteria Protein synthesis Gentamicin Micromonospora purpurea Broad spectrum Protein synthesis Rifamycin Streptomyces mediterranei Tuberculosis Protein synthesis Table 20.1 Histórico dos antibióticos e descobertas relacionadas Paul Ehrlich (1854 - 1915): Desenvolveu o conceito de toxicidade seletiva, indicando que determinado agente exibia uma ação danosa aos microrganismos, sem afetar as células do hospedeiro. Esperava encontrar um corante tóxico aos microrganismos ("bala mágica"). 1904 - Uso prático do vermelho de tripan, composto ativo contra o tripanossoma que causava a doença africana do sono. Ehrlich & Hata: realização de testes com compostos arsenicais, em coelhos com sífilis. Descobriram que o composto 606, arsfenamida, era ativo => Em 1910, foi lançado o medicamento Salvarsan (nome comercial da arsfenamida), para o tratamento da sífilis. 1896 - E. Duchesne: descobriu a penicilina, mas raramente tal pesquisador é citado, pois seus achados nunca foram devidamente publicados ou notificados, sendo esquecids durante vários anos. A. Fleming: Busca de um tratamento eficaz para os feridos na II Guerra Mundial. Foi o "segundo" descobridor da penicilina e tentou, sem sucesso, purificá-la em quantidades suficientes para ser descobridor da penicilina e tentou, sem sucesso, purificá-la em quantidades suficientes para ser utilizada como medicamento. 1944 - S. Waksman: descobrimento da estreptomicina (Streptomyces griseus), a partir do teste de cerca de 10.000 linhagens de bactérias e fungos do solo. Até 1953 - Isolamento de microrganismos produtores de cloranfenicol, neomicina, terramicina e tetraciclina. A partir de 1953 - a indústria investiu centenas de milhares de dólares na busca de novas drogas antimicrobianas, sendo que tal linha de pesquisa perdura até hoje em todo o mundo, empregando diversos tipos de abordagens. Alexander Fleming Microrganismos produtores Fungos - Penicillium e Cephalosporium - produzem antibioticos beta-lactam - penicilinas e cephalosporinas Servem como base para desenvolvimento de antibioticos beta-lactam semi- sinteticos, como amoxacillina e ampicillina Antibioticos Beta-lactam usados para tratar 30% de pacientes (for a do hospital – outpatients) com infecoes bacterianas The natural habitat of molds is soil. And although sex is sometimes involved, they reproduce by spore formation. They are foremost in their abilities to degrade organic matter, and they play their most important role in natures in biodegradation and the carbon cycle. Most of us know that molds will grow biodegradation and the carbon cycle. Most of us know that molds will grow on nearly anything that is organic and moist, so they are also responsible for a lot food spoilage as well as decomposition of our structural materials and textiles. "Nothing is forever", with molds around. Three colonies of a Penicillium mold growing on an agar medium. The green fuzzy appearance is the asexual spores of the fungus. 2. Actinomycetes, mainly Streptomyces species, produce tetracyclines, aminoglycosides (streptomycin and its relatives), macrolides (erythromycin and its relatives), chloramphenicol, ivermectin, rifamycins, and most other clinically- useful antibiotics that are not beta-lactams. Actinomycetes are the mainstay of the antibiotics industry. Actinomycetes are a group of branched bacteria that reproduce by spore formation. They come from a phylum of Bacteria, Actinobacteria, and from a phylum of Bacteria, Actinobacteria, and they are landed in Order Actinomycetales. Some of the representative family include such diverse bacteria as Actinomyces, Corynebacterium, Nocardia, Propionibacter, Streptomyces, Micromonospora and Frankia. Most actinomycetes are inhabitants of the soil. The characteristic odor of damp soil is due to the production of substances, called geosmins, by these bacteria Geosmin is a volatile compound that's Geosmin is a volatile compound that's made by soil bacteria like Streptomyces, as well as some plants like sugar beets, and cyanobacteria. It gets blamed quite often for making water taste like dirt. Only a small amount is required (10 nanograms per liter) for detection by the human palate (1) and it's been blamed for adding a "dirt-like" taste to many things like water, wine, apple-juice, and catfish. 5 especies de Streptomycin Metagenoma – 16S rDNA analise - actinomicetos 3. Bacillus species, such as B. polymyxa and B. subtilis, produce polypeptide antibiotics (e.g. polymyxin and bacitracin), and B. cereus produces zwittermicin. Bacillus species have the relatively rare ability to form a type of resting cell called an endospore. Bacilli are Gram-positive, rod-shaped, aerobic bacteria that live in the soil. They play an important ecological role in aerobic decomposition, biodegradation and mineral recycling. A swirl of Bacillus mycoides colonies growth amidst other bacteria and molds from the soil. The swirls are always counterclockwise, at least in the Northern These organisms all have in common that they live in soil and they form some sort of a spore or resting structure. It is notknown why these microorganisms produce antibiotics, but the answer may be in the obvious - it affords them some nutritional or spatial advantage in their habitat by antagonizing the competition; or it may be in the subtle - it acts as some sort of hormone or signal molecule associated with sporulation or dormancy or germination. Antibiotics are secondary metabolites and they are produced at the same time that the cells begin their sporulation processes. counterclockwise, at least in the Northern Hemisphere Toxicidade seletivo de antibioticos = altamente efetivo contra microrganismo, toxicidade minimo contra humanos Na pratica – expresso como therapeutic index (TI) da droga: = razao entre dosagem toxico (no paciente) e dosagen terapico (para eliminar a infecao) Maior o indice = droga mais seguro para uso humano The selective toxicity of antibiotics is brought about by finding vulnerable targets for the drug in the microbe that do not exist in the animal (eucaryote) that is given the drug. Most antibiotics in clinical usage are directed against bacterial cell wall synthesis, Most antibiotics in clinical usage are directed against bacterial cell wall synthesis, bacterial protein synthesis, or bacterial nucleic acid synthesis, which are unique in some ways to bacteria. For example, the beta lactam antibiotics (penicillin and its relatives) inhibit peptidoglycan synthesis in the cell wall. Humans have neither a cell wall nor peptidoglycan and so are unaffected by the action of the drug. Other antibiotics, including streptomycin and the tetracyclines, target bacterial protein synthesis because bacterial ribosomes (termed 70S ribosomes) are different from the ribosomes (80S) of humans and other eucaryotic organisms. Antibiotics such as the flouroqinolones (e.g. ciprofloxacin) inhibit procaryotic (not eucaryotic) DNA replication, and rifamycins inhibit bacterial (not eucaryotic) DNA transcription. • Quanto à ação: "státicos" ou "cidas" Os "cidas" podem ser "státicos" dependendo da concentração, ou do tipo de organismo. Os "staticos" tem sua ação vinculada à resistência do hospedeiro. • CMI e CML: 2 parâmetros que indicam a eficiência da droga. A droga "cida" geralmente elimina o agente em concentrações de 2 a 4 vezes maior que a "stática“.maior que a "stática“. • Atingir concentrações efetivas nos tecidos e entrar em contato com o microrganismo. • Não alterar os mecanismos naturais de defesa do hospedeiro. Teste de Susceptibilidade de bacterias � CMI - Teste de Difusão em Placa The agar diffusion test (Bauer-Kirby test) A procedure commonly used in clinical labs to determine antimicrobial susceptibility is the Bauer-Kirby disc diffusion method. In this test, the in vitro response of bacteria to a standardized antibiotic-containing disc has been correlated with the clinical response of patients given that drug. Concentração Bactericida Mínima - CML Antimicrobial Agents Used in the Treatment of Infectious Disease Examination of the foregoing table reveals that there are a handful of fundamental ways that antibacterial antibiotics work as therapeutic agents. Recall that the target of an antibiotic should be unique to the bacterium and not found, or not accessible to the antibiotic, in the patient. These are the most important targets in bacteria that have been exploited so far. 1. Attack bacterial cell wall synthesis. Bacteria have murein in their cell walls, not found in the host, and murein (peptidoglycan) is essential to the viability of the bacterium. 2. Interfere with protein synthesis. Attack is almost always at the level of translation using 70S ribosomes in the translation machinery. 70S cytoplasmic ribosomes are absent in eucaryotes. 3. Interference with nucleic acid synthesis (RNA and DNA), which exploits differences between RNA 3. Interference with nucleic acid synthesis (RNA and DNA), which exploits differences between RNA polymerases and DNA replication strategies in bacteria and eucaryotes. 4. Inhibition of an essential metabolic pathway that exists in the bacterium but does not exist in the host. This is usually brought about through the use of competitive chemical analogs for bacterial enzymatic reactions. 5. Membrane inhibition or disruption doesn't work too well because of the similarities between eucaryotic and bacterial membranes. However, the outer membrane of Gram-negative bacteria is a reasonable point of attack and some membrane inhibitors are included in the discussion below Mecanismos de ação de drogas antimicrobianas Figure 20.2 Inibição da síntese da Parede Celular Cell wall synthesis inhibitors generally inhibit some step in the synthesis of bacterial peptidoglycan. They exert their selective toxicity against bacteria because humans cells lack cell walls. Beta lactam antibiotics. Chemically, these antibiotics contain a 4-membered beta lactam ring. They are the products of two genera of fungi, Penicillium and Cephalosporium, and are correspondingly represented by the penicillins and cephalosporins. Chemical structures of some beta-lactam antibiotics. Clockwise: penicillin, cephalosporin, monobactam, carbapenem. Note the characteristic structure of the beta lactam ring.lactam ring. The beta lactam antibiotics are stereochemically related to D-alanyl-D-alanine, which is a substrate for the last step in peptidoglycan synthesis, the final cross-linking between between peptide side chains. Penicillins bind to and inhibit the carboxypeptidase and transpeptidase enzymes that are required for this step in peptidoglycan biosynthesis. Beta lactam antibiotics are bactericidal and require that cells be actively growing in order to exert their toxicity. Different beta lactams differ in their spectrum of activity and their effect on Gram-negative rods, as well as their toxicity, stability in the human body, rate of clearance from blood, whether they can be taken orally, ability to cross the blood-brain barrier, and susceptibility to bacterial beta-lactamases. Natural penicillins, such as penicillin G or penicillin V (benzyl penicillin), are produced by fermentation of Penicillium chrysogenum. They are effective against streptococci, gonococci and staphylococci, except where resistance has developed. They are considered narrow spectrum since they are not effective against Gram- negative rods. Penicillin G (Benzylpenicillin) is typically given by parenteral administration because it is unstable in the acid of the stomach. However, this achieves higher tissue concentrations than orally-administered penicillins and this increases its antibacterial potential. "PenG" may be used in treatment of bacterial endocarditis, gonorrhea, syphilis, meningitis, and pneumonia. •Modo de Acao geral de penicilinas: •Prevencao de sintese de tetrapeptideos (ligacoes cruzados no peptideoglicano, na parede celular) •Penicilina liga com as enzimas transpeptidase, carboxipeptidase e endopeptidase) localizam-se logo abaixo da parede celular e são denominadas de " proteínas ligadoras de penicilina" (penicillin-binding proteins – PBPs). •Resultado – as enzimas nao podem catalizar mais o reacao de transpeptidase, que faz a ligação entre as cadeias peptídicas, impedindo o desenvolvimento da estrutura normal do peptidoglicano •Celulas existentes nao sao danificados •Novas celulas crescem anormal – sem rigidez na parede celular – suscetivel a lise osmotica•Novas celulas crescem anormal – sem rigidez na parede celular – suscetivel a lise osmotica •Penicilina G: inibe G+vos (mas sensivel a B-lactamase – enzima produzido por bacterias resistentes a penicilina) •Ampicilina: inibe G+vos e G-vos (resistente a B-lactamase) Gram+ e Gram – Qual a diferença? Penicillin Mode of Action – Inibicao de atividade enzimatica: Semelhanca entre estrutura de penicilina e cadeia peptidica na parede celular bacteriana – explica modo de acao de antibioticos beta- lactam Parede Celular � Estrutura complexo, semi rigida, responsavel pela forma da celula � Existem diferenças em bacterias gram-positivas, gram-negativas ,arquibacterias e micoplasmas � Circunda a membrana plasmatica (= citoplasmática) � Protege a celula: prevenir a ruptura da celula quando a pressão da água dentro e maior do que fora � Forma usado para diferenciar principais tipos de bacterias Composição: � Uma rede macromolecular – PEPTIDEOGLICANA (= MUREÌ NA) � Composto de um dissacarídeo repetitivo unido por polipeptideos, formando um rede � dissacarideo e composto de monossacarídeos de NAG e NAM (N-acetilglicosamina e N- acetilmurâmico) � Moleculas alternadas de NAM e NAG (10 – 65 açucares) � Filas adjacentes ligados por polipeptídeos Parede celulare de celulas Gram-positivas � Muitas camadas de peptideoglicana � Acidos teicóicos (um alcool – glicerol ou ribitol) e fosfato � Acido lipoteicóico: atravessa as camadas de peptideoglicana para tocar a membrana plasmatica � Acido tecóico de parede: ligando as camadas de peptideoglicana � Acidos teicoicos tem carga negativa – regulam entrada de cations para dentro e fora da celula � Acidos teicoicos fornecem boa parte da especificidade antigenica da parede (usado na identificação de certos bacterias) identificação de certos bacterias) Parede celular de celulas Gram-negativos •Uma ou algumas camadas de peptideoglicana mais uma membrana externa •Peptideoglicana no espaço periplásmico (entre membrana externa e membrana plasmatico), ligado a lipoproteinas •Não tem acidos teicoicos •Pouco peptideoglicana = suscetivel ao rompimento mecanico •Membrana externa: •Contem lipoproteinas, lipopolissacaridios, fosfolipidios •Carga negativa forte (evita ação de fagocitos) •Barreira para antibioticos (que atacam peptideoglicana) •Porinas de proteinas: canais na membrana para o •Porinas de proteinas: canais na membrana para o movimento de moleculas (nucleotideos, dissacarideos, peptideos, aminoacidos, vitaminas) (e tambem invasores – eg virus) •Lipopolissacarideos: contem polissacarideo O (atua como atigeno e util na identificação de Gram-negativos), e Lipideo A (uma endotoxina – toxico quando presente no sangue o trato gastrintestinal) Penicillium notatum inibindo a bacteria Mycococcus luteus Efeito morfogenetico: �Esquerda – celulas bacterianas sem ampicilina no meio �Direito – celulas bacterianas com ampicilina (celulas maiores (e mais fragil), e menos divisao celular) Link: http://helios.bto.ed.ac.uk/bto/microbes/penicill.htm#crest Semisynthetic penicillins first appeared in 1959. A mold produces the main part of the molecule (6-aminopenicillanic acid), which can be modified chemically by the addition of side chains. Many of these compounds have been developed to have distinct benefits or advantages over penicillin G, such as increased spectrum of activity (effectiveness against Gram-negative rods), resistance to penicillinase, effectiveness when administered orally, etc.; amoxicillin and ampicillin have broadened spectra against Gram-negative bacteria and are effective orally; methicillin is penicillinase-resistant. The semisynthetic beta-lactam, amoxicillin. Amoxicillin is usually the drug of choice within the class because it is better absorbed the drug of choice within the class because it is better absorbed following oral administration than other beta-lactam antibiotics. It is susceptible to degradation by bacterial beta-lactamase enzymes so it may be given with calvulanic acid (below) to decrease its susceptibility. It is used against a wide range of Gram-positive bacteria, including Streptococcus pyogenes, penicillin-sensitive Streptococcus pneumoniae, non beta-lactamase producing strains of Staphylococcus aureus and Enterococcus faecalis. Susceptible Gram-negative organisms include non beta-lactamase producing strains of Haemophilus influenzae, Neisseria gonorrhoeae and N. meningitidis. Penicilinas Figure 20.6 Cephalosporins are beta lactam antibiotics with a similar mode of action to penicillins. They are produced by species of Cephalosporium molds. The have a low toxicity and a somewhat broader spectrum than natural penicillins. They are often used as penicillin substitutes against Gram-negative bacteria and in surgical prophylaxis. They are subject to degradation by some bacterial beta-lactamases, but they tend to be resistant to beta-lactamases from S. aureus. The core structure of cephalosporin. Substituent cephalosporin. Substituent groups added at position X on the six-membered ring generates variants of the antibiotic. Glycopeptides, such as the antibiotic vancomycin, inhibit both transglycosylation and transpeptidation reactions during peptidoglycan assembly. They bind to the muropeptide subunit as it is transferred out of the cell cytoplasm and inhibit subsequent polymerization reactions. Vancomycin is not effective against Gram- negative bacteria because it cannot penetrate their outer membrane. However, it has become important in clinical usage for treatment of infections by strains of Staphylococcus aureus that are resistant to virtually all other antibiotics (MRSA). Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram- positive bacteria. It has traditionally been reserved as a drug of "last resort", used only after treatment with other of "last resort", used only after treatment with other antibiotics had failed, although the emergence of vancomycin-resistant organisms means that it is increasingly being displaced from this role by linezolid and the carbapenems. Vancomicina: Se liga a D-Ala-D-Ala, impedindo o crosslinking de G + Alternativa a MARSA
Compartilhar